Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Rogawski

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Archives of Neurology|June 11, 2008
Common pathophysiologic mechanisms in migraine and epilepsyMichael A Rogawski
Epilepsy & Behavior : E&B|March 1, 2003
Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs?Michael A. Rogawski
Epilepsy Research|December 27, 2005
Molecular targets versus models for new antiepileptic drug discoveryMichael A Rogawski
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 1, 2009
Convection-enhanced delivery in the treatment of epilepsyMichael A Rogawski
Nature Medicine|September 8, 2005
Astrocytes get in the act in epilepsyMichael A Rogawski
Epilepsy Currents|April 5, 2011
A new policy for disclosure of competing interestsMichael A Rogawski
Epilepsy Currents|June 21, 2011
Revisiting AMPA receptors as an antiepileptic drug targetMichael A Rogawski
Epilepsy Currents|August 17, 2004
Antiepileptogenesis by Deep Brain StimulationMichael A. Rogawski
Epilepsia|May 8, 2013
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugsMichael A Rogawski
Science (New York, N.Y.)|September 16, 2006
Support for the NIH public access policyMichael A Rogawski, Peter Suber
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Archives of Neurology|June 11, 2008
Common pathophysiologic mechanisms in migraine and epilepsyMichael A Rogawski
Epilepsy & Behavior : E&B|March 1, 2003
Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs?Michael A. Rogawski
Epilepsy Research|December 27, 2005
Molecular targets versus models for new antiepileptic drug discoveryMichael A Rogawski
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 1, 2009
Convection-enhanced delivery in the treatment of epilepsyMichael A Rogawski
Nature Medicine|September 8, 2005
Astrocytes get in the act in epilepsyMichael A Rogawski
Epilepsy Currents|April 5, 2011
A new policy for disclosure of competing interestsMichael A Rogawski
Epilepsy Currents|June 21, 2011
Revisiting AMPA receptors as an antiepileptic drug targetMichael A Rogawski
Epilepsy Currents|August 17, 2004
Antiepileptogenesis by Deep Brain StimulationMichael A. Rogawski
Epilepsia|May 8, 2013
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugsMichael A Rogawski
Science (New York, N.Y.)|September 16, 2006
Support for the NIH public access policyMichael A Rogawski, Peter Suber
Pageof 13